Evofem Biosciences's total assets for Q3 2025 were $13.81M, a decrease of -4.00% from the previous quarter. EVFM total liabilities were $83.98M for the fiscal quarter, a -0.03% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.